'I'm a pharmacist - worrying rise in patients needing organ removed with weight loss jabs'
Deborah Grayson, a top pharmacist and nutritional therapist, has warned that weight loss medication can cause an inflamed ...
AbbVie Is Preparing To Challenge Eli Lilly And Novo Nordisk
AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.
FingerLakes1.com1d
GLP-1 Therapy: Unlocking the Potential of Modern Weight Loss Solutions
GLP-1 therapy is a groundbreaking approach in the treatment of obesity and metabolic health issues. GLP-1, or glucagon-like ...
Diabetes.co.uk3d
Retatrutide: How it Works, Evidence, Side Effects
Retatrutide mimics the effects of naturally occurring gut hormones to improve metabolic health. Stimulating insulin release ...
Roche And Zealand Team Up To Develop Petrelintide
Roche & Zealand join forces on petrelintide, advancing obesity treatments with innovative amylin analogs. Find out why this ...
Morgan Stanley says REDEFINE-2 misses opportunity to differentiate in diabetes
Morgan Stanley notes Novo Nordisk (NVO) disclosed headline data for CagriSema in REDEFINE-2, with a weight loss and safety ...
Novo Nordisk under pressure as obesity drug disappoints in diabetes trial
Shares of Novo Nordisk (NVO) are sliding in Monday trading after the company announces results for its trial of weight-loss drug CagriSema.
Turning it around: Former boxer focuses on physical, mental health
ARGILLITE Professional boxer Jeremy “The Beast” Bates has conquered challenges in his sport and on the small screen, but one win many don’t know about is his return to good health. Divorce, among ...
EL PAÍS English8d
New anti-obesity drugs already outperform Ozempic
The pharmaceutical industry is not stopping there. There are already 100 new drug candidates in trials, all vying for a slice ...
Business Wire8d
Arrowhead Pharmaceuticals Showcases Two Clinical-Stage RNAi-Based Candidates to Treat Obesity and Metabolic Diseases
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced presentation of preclinical data supporting the advancement of ...
Medindia9d
Iv m Health Raises Alarm as FDA Deadline Threatens Obesity Treatment Access
In recognition of World Obesity Day,�Ivim Health is proud to advocate on behalf of patients on their health journeys by providing personalized and effective care, guided by medical professionals who ...